If you experience persistent muscle weakness, fatigue and skin changes that don't seem to fade, it could be more than just ...

The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.

can also occur in dermatomyositis but is commonly seen in overlap with another connective tissue disease, such as systemic sclerosis. The immunoprecipitation assay is the gold standard for ...

Several known risk factors of Dermatomyositis (DM) include female sex, genetics, ultraviolet radiation, prior respiratory disease, viral and bacterial infections, medications, and pollutants and ...

Abdelghani M, et al . Experimental myositis: an optimised version of C-protein-induced myositis. RMD Open 2025;11:e004558. doi: 10.1136/rmdopen-2024–0 04 558 In this article, the abstract has been ...

A lot of people don’t know that I am an autoimmune hepatitis patient. I have a liver disease, it was diagnosed in 2020,” said Sana Makbul.

The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis,” published in the March 2025 issue of Rheumatology by ...

such as polymyositis and dermatomyositis. Elevated interleukin (IL)-17 levels are increasingly implicated in experimental models of autoimmune diseases, but Hitoshi Kohsaka and colleagues have now ...

Keep abreast with the latest news related to Polymyositis there are 13 news items on Polymyositis that covers updates, breakthroughs and in-depth reports. We provide you with a free downloadable ...